This inventor holds 1 USPTO granted patent. Top assignee: University of Regensburg. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Elisabeth Grünstein: Innovator in HDAC6 Inhibitors
Introduction
Elisabeth Grünstein is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of HDAC6 inhibitors. Her work focuses on creating small molecule compounds that have the potential to treat various diseases, including cancer.
Latest Patents
Grünstein holds a patent for "HDAC6 inhibitors, with improved solubility and their uses." This invention relates to small molecule compounds that act as HDAC inhibitors. The patent outlines methods for improving solubility by introducing basic substituents, which can lead to the creation of pharmaceutically acceptable salts. Additionally, it includes methods for synthesizing these compounds and their applications in treatment.
Career Highlights
Elisabeth Grünstein is affiliated with the University of Regensburg, where she conducts her research. Her innovative work has garnered attention in the scientific community, contributing to advancements in cancer treatment.
Collaborations
Grünstein collaborates with esteemed colleagues such as Siavosh Mahboobi and Herwig Pongratz. Their combined expertise enhances the research and development of effective therapeutic solutions.
Conclusion
Elisabeth Grünstein's contributions to the field of HDAC6 inhibitors exemplify her dedication to advancing medical science. Her innovative approaches and collaborative efforts continue to pave the way for new treatments in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile